期刊
PEPTIDES
卷 29, 期 11, 页码 1965-1973出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.peptides.2008.06.021
关键词
Prodrug; Cancer; Hydrogel; Drug targeting; Drug activation
资金
- National Institutes of Health [EY014357, NS055095]
- American Brain Tumor Association
- Kathy Murphy Translational Research Grant
- Vahlteich Endowment
- [C06 RR15482]
To utilize biologic mechanisms to elicit controlled release in response to disease, protease-sensitive devices have been created. Hydrogels were created with pendant peptide-drug complexes. For the matrix metalloproteases (MMPs) examined, a length of six amino acids greatly improved the specificity of the peptide (k(cat)/K-m similar to 2.4 +/- 0.1 x 10(4) M (1) s (1)) over shorter sequences (k(cat)/K-m similar to 4.4 +/- 0.2 x 10(2) M (1)s (1)). The peptides did not exhibit anti-proliferative effects upon cancer cells, and peptide-platinum complexes showed similar anti-proliferative effects upon the cancer cells compared to the free platinum drugs. Once the peptide-drug complex was incorporated into the hydrogels, the release was dependent upon the presence of MMP in the solution with approximately 35% of platinum released from hydrogels in the presence of MMP and only 10% without MMP in the week examined. The released drug exhibited the expected anti-proliferative activity over several days of incubation. The MMP selective drug delivery holds much potential for treatment of cancer and other diseases. (C) 2008 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据